Jauculan, Rose Mae L.

HRN: 27-17-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/21/2025
05/27/2025
IV
600 Mg
Q8h
Cellulitis
Waiting Final Action 
05/22/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/22/2025
05/28/2025
IV
1.5g
Q6h
Cellulitis
Waiting Final Action 
05/29/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/29/2025
05/30/2025
IV
4.5gms
Q6
Cellulitis
Remove - Pending Acceptance
05/29/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/31/2025
06/05/2025
IV
4.5gms
Q8
Cellulitis
Remove - Pending Acceptance
05/31/2025
MUPIROCIN 2%, 15G (TUBE)
05/31/2025
06/06/2025
TOPICAL
Apply Thinly
Bid
Cellulitis
Waiting Final Action 
05/31/2025
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
05/31/2025
06/06/2025
TOPICAL
Apply Thinly
Bid
Cellulitis
Waiting Final Action 
06/02/2025
CLINDAMYCIN 300MG (CAP)
06/02/2025
06/09/2025
PO
1 Tab
Q6h
Cellulitis, Left Leg
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: